Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

The Quiet AI Transformation Reshaping Small Business Operations

Robert Sasse by Robert Sasse
September 6, 2025
in AI & Quantum Computing, Analysis, Tech & Software
0
Thryv Holdings Stock
0
SHARES
173
VIEWS
Share on FacebookShare on Twitter

While much of the artificial intelligence conversation focuses on enterprise-level applications, a significant shift is occurring within the small and medium-sized business sector. Thryv Holdings has successfully transitioned AI from theoretical concept to practical implementation for thousands of small businesses. The central question for investors remains whether the company’s operational success can eventually translate into market performance.

Practical Applications Driving Real Growth

Thryv’s approach to artificial intelligence emphasizes tangible business solutions rather than abstract promises. The company’s recent publication, “Growth Masterclass – A Simple AI Playbook for Real Business Growth,” demonstrates this focus on actionable tools that enhance efficiency and drive expansion. The underlying message is clear: AI has evolved from future speculation to present-day competitive necessity.

This practical strategy appears to be delivering measurable results. For the second quarter of 2025, Thryv reported a substantial 48 percent year-over-year increase in SaaS revenue—a figure that commands attention even within the rapidly growing software industry. Concurrently, the company reduced its liabilities by $26 million, demonstrating disciplined financial management alongside impressive growth metrics.

External Validation and Market Recognition

The market has taken notice of Thryv’s progress. The company’s inclusion in the Constellation ShortList™ for B2B Marketing Automation Platforms and its recognition as one of Selling Power Magazine’s “60 Best Companies to Sell For 2025” underscore its growing industry standing.

Should investors sell immediately? Or is it worth buying Thryv Holdings?

Analyst sentiment has also turned increasingly positive. Zacks Equity Research recently revised its EPS estimates upward, reflecting heightened expectations for future profitability. Investors will have the opportunity to hear directly from management during the upcoming B. Riley Securities’ 8th Annual Consumer & TMT Conference.

The Performance Paradox

Despite these strong operational achievements and external validations, Thryv’s market performance tells a different story. The stock has declined more than 12 percent since the beginning of the year and nearly 30 percent over the past twelve months. Shares currently trade approximately 37 percent below their 52-week high.

This divergence presents a compelling question for market participants: does Thryv represent a fundamentally undervalued opportunity, or are markets identifying concerns not immediately apparent in the operational data? The coming weeks will reveal whether the company’s underlying business strength can ultimately propel its market valuation.

Ad

Thryv Holdings Stock: Buy or Sell?! New Thryv Holdings Analysis from March 25 delivers the answer:

The latest Thryv Holdings figures speak for themselves: Urgent action needed for Thryv Holdings investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Thryv Holdings: Buy or sell? Read more here...

Tags: Thryv Holdings
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Pinduoduo Stock
Asian Markets

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

March 25, 2026
Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Alphabet Stock
AI & Quantum Computing

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Next Post
Hillman Solutions Stock

Hillman Solutions Embarks on Major Cincinnati Logistics Overhaul

Air Products Stock

Industrial Gas Giant Navigates Strategic Shift Amid Hydrogen Ambitions

Extreme Networks Stock

Extreme Networks Stock Soars on AI Networking Strength and Record Performance

Recommended

Technology Blockchain Trading online

Analyst Reaffirms Bullish Outlook on CyberArk Software with 300 Price Target

2 years ago
Pepsi Stock

PepsiCo’s Leadership Shift Amid Market Headwinds

4 months ago
Nvidia Stock

Nvidia’s AI Dominance Faces Critical Test as Key Client Explores Alternatives

4 months ago
Palantir Stock

Palantir Shares Navigate Market Turbulence

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Trending

Pinduoduo Stock
Asian Markets

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

by SiterGedge
March 25, 2026
0

All eyes are on Pinduoduo this Wednesday as the company prepares to release its fourth-quarter 2025 financial...

XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Oracle Stock

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant
  • XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch
  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com